Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden · Delayed Price · Currency is SEK 6.12
-0.13 (-2.14%)
Feb 26, 2026, 5:29 PM CET
-67.95% (1Y)
| Market Cap | 126.13M -54.8% |
| Revenue (ttm) | 152.35M -23.3% |
| Net Income | 127.24M |
| EPS | 0.08 |
| Shares Out | 20.61M |
| PE Ratio | 0.99 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 44,450 |
| Average Volume | 67,344 |
| Open | 6.26 |
| Previous Close | 6.26 |
| Day's Range | 6.03 - 6.40 |
| 52-Week Range | 6.10 - 38.25 |
| Beta | 0.79 |
| RSI | 22.38 |
| Earnings Date | Feb 20, 2026 |